Volumetric comparison of positron emission tomography/computed tomography using 4′-[methyl-11C]-thiothymidine with 2-deoxy-2-18F-fluoro-D-glucose in patients with advanced head and neck squamous cell carcinoma. Issue 3 (March 2015)
- Record Type:
- Journal Article
- Title:
- Volumetric comparison of positron emission tomography/computed tomography using 4′-[methyl-11C]-thiothymidine with 2-deoxy-2-18F-fluoro-D-glucose in patients with advanced head and neck squamous cell carcinoma. Issue 3 (March 2015)
- Main Title:
- Volumetric comparison of positron emission tomography/computed tomography using 4′-[methyl-11C]-thiothymidine with 2-deoxy-2-18F-fluoro-D-glucose in patients with advanced head and neck squamous cell carcinoma
- Authors:
- Ito, Kimiteru
Yokoyama, Junkichi
Miyata, Yoko
Toyohara, Jun
Okasaki, Momoko
Minamimoto, Ryogo
Morooka, Miyako
Ishiwata, Kiichi
Kubota, Kazuo - Abstract:
- Abstract : Objective: We prospectively compared the diagnostic value of PET/computed tomography (CT) findings using the tracers 4′-[methyl- 11 C]-thiothymidine ( 11 C-4DST) and 2-deoxy-2- 18 F-fluoro-D-glucose ( 18 F-FDG) in patients with head and neck squamous cell carcinoma (HNSCC). Patients and methods: Thirty-eight patients with advanced HNSCC underwent 11 C-4DST PET/CT and 18 F-FDG PET/CT before treatment. Maximum standardized uptake values (SUVmax ) were measured for both PET/CT studies; in addition, total lesion glycolysis (TLG) of 18 F-FDG PET/CT and total lesion proliferation (TLP) of 11 C-4DST PET/CT were measured. Absolute TLG and TLP values as well as values with various SUV thresholds were measured. All patients were followed up for 13.5±7.5 months (mean±SD) to monitor recurrence. Results: A statistically significant correlation was observed between the primary tumor SUVmax for 11 C-4DST PET/CT and 18 F-FDG PET/CT ( r =0.46, P <0.01). TLP values with SUV thresholds strongly correlated with TLG values relative to the same thresholds ( r =0.60–0.92, P <0.001). Nine of the 38 patients with post-treatment recurrence were identified. Receiver operating characteristic curves for TLG3.0 and TLP2.5 showed the highest prognostic ability for recurrence; the sensitivity and specificity of TLG3.0 were 89 and 72%, respectively, and the sensitivity and specificity of TLP2.5 were 89 and 55%, respectively. Conclusion: In patients with advanced HNSCC, the TLP of 11 C-4DST PET/CTAbstract : Objective: We prospectively compared the diagnostic value of PET/computed tomography (CT) findings using the tracers 4′-[methyl- 11 C]-thiothymidine ( 11 C-4DST) and 2-deoxy-2- 18 F-fluoro-D-glucose ( 18 F-FDG) in patients with head and neck squamous cell carcinoma (HNSCC). Patients and methods: Thirty-eight patients with advanced HNSCC underwent 11 C-4DST PET/CT and 18 F-FDG PET/CT before treatment. Maximum standardized uptake values (SUVmax ) were measured for both PET/CT studies; in addition, total lesion glycolysis (TLG) of 18 F-FDG PET/CT and total lesion proliferation (TLP) of 11 C-4DST PET/CT were measured. Absolute TLG and TLP values as well as values with various SUV thresholds were measured. All patients were followed up for 13.5±7.5 months (mean±SD) to monitor recurrence. Results: A statistically significant correlation was observed between the primary tumor SUVmax for 11 C-4DST PET/CT and 18 F-FDG PET/CT ( r =0.46, P <0.01). TLP values with SUV thresholds strongly correlated with TLG values relative to the same thresholds ( r =0.60–0.92, P <0.001). Nine of the 38 patients with post-treatment recurrence were identified. Receiver operating characteristic curves for TLG3.0 and TLP2.5 showed the highest prognostic ability for recurrence; the sensitivity and specificity of TLG3.0 were 89 and 72%, respectively, and the sensitivity and specificity of TLP2.5 were 89 and 55%, respectively. Conclusion: In patients with advanced HNSCC, the TLP of 11 C-4DST PET/CT strongly correlated with the TLG of 18 F-FDG PET/CT. Although there were no large differences between these values, the receiver operating characteristic curves of the absolute TLG had slightly better prognostic ability for recurrence. … (more)
- Is Part Of:
- Nuclear medicine communications. Volume 36:Issue 3(2015:Mar.)
- Journal:
- Nuclear medicine communications
- Issue:
- Volume 36:Issue 3(2015:Mar.)
- Issue Display:
- Volume 36, Issue 3 (2015)
- Year:
- 2015
- Volume:
- 36
- Issue:
- 3
- Issue Sort Value:
- 2015-0036-0003-0000
- Page Start:
- Page End:
- Publication Date:
- 2015-03
- Subjects:
- 11C-4DST -- cell proliferation -- 18F-FDG -- head and neck squamous cell cancer -- PET/CT -- thymidine
Nuclear medicine -- Periodicals
616.07575 - Journal URLs:
- http://journals.lww.com/nuclearmedicinecomm/pages/default.aspx ↗
http://journals.lww.com/pages/default.aspx ↗
http://www.lww.com/Product/0143-3636 ↗ - DOI:
- 10.1097/MNM.0000000000000241 ↗
- Languages:
- English
- ISSNs:
- 0143-3636
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6180.923000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 5224.xml